Moneycontrol PRO
HomeNewsBusinessMarketsTop Nifty Midcap Losers: Colgate, BSE Ltd, Mankind Pharma, Emami, Dixon Technologies stocks fall up to 5% today

Top Nifty Midcap Losers: Colgate, BSE Ltd, Mankind Pharma, Emami, Dixon Technologies stocks fall up to 5% today

The NIFTY MIDCAP 150 index reflects the performance of these and other mid-sized companies, providing a broad view of this market segment.

May 22, 2025 / 11:08 IST
Disclaimer This is an AI-assisted live blog with updates sourced from multiple news outlets and agencies Disclaimer

During today's trading session, several stocks within the NIFTY MIDCAP 150 experienced notable declines. Among the top losers were Colgate, BSE Limited, Mankind Pharma, Emami, and Dixon Technologies.

Colgate led the declines with a drop of 5.13%, settling at Rs 2,522.90. BSE Limited followed, decreasing by 4.18% to Rs 6,999.50. Mankind Pharma's stock also saw a significant dip of 3.8%, reaching Rs 2,435.10. Emami's shares fell by 2.81%, closing at Rs 590.65, while Dixon Technologies recorded a decrease of 2.57%, ending the session at Rs 15,210.00.

Financial Performance Snapshot

To provide a deeper understanding of these companies, here's a summary of their recent financial performance based on available data:

CompanyRevenue (Mar 2025)Net Profit (Mar 2025)EPS (Mar 2025)
Mankind PharmaRs 10,292.54 CrRs 461.19 CrRs 77.59
EmamiRs 474.95 CrRs 3.92 CrRs 0.45
Mankind Pharma
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue (Cr)6,448.1710,697.0812,192.0117,690.9038,860.10
Net Profit (Cr)159.79190.39253.46364.681,215.20
EPS (Rs)27.4932.3142.9262.84205.70

Mankind Pharma reported a revenue of Rs 10,292.54 Cr for March 2025, compared to Rs 4,657.97 Cr in March 2024. The net profit for the same period was Rs 461.19 Cr, a significant increase from Rs 94.49 Cr. The EPS stood at Rs 77.59, up from Rs 16.31 in the previous year.

Emami

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue (Cr)1216.271957.712308.111993.841928.04
Net Profit (Cr)51.06114.8069.1784.3026.01
EPS (Rs)8.4318.1710.6213.123.49

Emami's revenue for March 2025 was Rs 474.95 Cr, a slight decrease from Rs 484.47 Cr in March 2024. The net profit for the period was Rs 3.92 Cr, a significant drop from Rs 27.19 Cr. The EPS also declined to Rs 0.45 from Rs 4.29 in the previous year.

The NIFTY MIDCAP 150 index reflects the performance of these and other mid-sized companies, providing a broad view of this market segment.

Alpha Desk
first published: May 22, 2025 11:08 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai